Exagen Inc.XGNNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank58
5Y CAGR+38.0%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
+38.0%/yr
Long-term compound
Percentile
P58
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202519.65%
20245.89%
202315.33%
2022-5.66%
202115.07%
20203.93%
201924.50%
201821.01%
20170.00%
201553.87%